Identifying sites of epigenetic modification can shed light on developmental pathways, pathogenic processes, transcriptional regulation, and serve as biomarkers for disease.
HudsonAlpha Discovery provides a range of epigenetic sequencing services to advance all phases of research studies, including basic, discovery, translational, pre-clinical, and clinical research.